OTC - ACTIVE INGREDIENT SECTION
Hydrangea arborescens 30C
Hydrangea arborescens 30C
Bedwetting*
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen
If pregnant or breast-feeding ask a health professional before use
Keep out of reach of children
5 pellets 3 times a day until symptoms are relieved
Do not use if pellet dispenser seal is broken, contains approx 80 pellets
lactose, sucrose
1-800-BOIRON-1, Newtown Square, PA 19073-3267, info@boironusa.com
These "Uses" have not been evaluated by the FDA
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0220-2514-41 | 2023-11-13 | C162847 | 48780-1 | f386c649-b6eb-0266-e053-dadaa90a7c1a | Hydrangea arborescens |
| 0220-2514-41 | 2023-01-30 | C162847 | 48780-1 | f386c649-b6eb-0266-e053-dadaa90a7c1a | Hydrangea arborescens |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0220-2514-41 | Hydrangea arborescens | 30 [hp_C] in 1 TUBE | PELLET | 30 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0220-2514 | 0220-2514-41 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SUCROSE | C151H8M554 | IACT |
| LACTOSE, UNSPECIFIED FORM | J2B2A4N98G | IACT |
| HYDRANGEA ARBORESCENS ROOT | SFK828Q2DE | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrangea arborescens | HYDRANGEA ARBORESCENS ROOT | Boiron | 7c747cb5-7493-1d0f-e053-2991aa0ad10b | 2023-11-13 | 0220-2514-41 0220-2514 00220251441 0a0d95f0-5c6b-6afd-e063-6394a90a6ae6 7c747cb5-7493-1d0f-e053-2991aa0ad10b |
Adverse event summaries are temporarily unavailable. Other product information remains available.